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Parc appears to directly interact with p53 with the NParc-ing p53 in the Cytoplasm
terminus of Parc binding to the C terminus of p53. This
finding is consistent with previous observations that p53
exists in large aggregates within the cytoplasm of neuro-
blastoma cells and that a C-terminal p53 peptide, whichNikolaev et al. (this issue of Cell) report the identifica-
in theory could compete for binding to Parc, efficientlytion of a parkin-like protein, Parc, and its role in an-
induces nuclear accumulation of endogenous p53 (Os-choring the tumor suppressor protein p53 in the cyto-
termeyer et al., 1996). The observation by Gu and col-plasm reveals yet another level of control of p53
leagues that both the p53-interaction domain and CCHfunction. Regulation of the subcellular localization of
domain of Parc are required to retain p53 within thep53 by Parc may serve as a novel target in treatment
cytoplasm suggests that Parc serves as a bridge be-of certain types of tumors.
tween p53 and a cytoplasmic structure. Indeed, cy-
toskeletal proteins (e.g., vimentin) can contribute to thep53 or genes that affect p53 function are mutated in
cytoplasmic sequestration of p53 (Klotzsche et al.,most, if not all, human tumors. By modulating cell cycle
1998). Moreover, previous studies have demonstratedprogression or apoptosis, p53 appears to facilitate opti-
that the glucocorticoid receptor (GR) retains p53 withinmal cellular responses to a variety of stresses, such as
the cytoplasm of neuroblastoma cells and that specificDNA damage or hypoxia (Giaccia and Kastan, 1998).
antagonists of this receptor induce nuclear accumula-Since p53 functions as a transcription factor, it must
tion of p53 (Sengupta et al., 2000). Such findings suggestbe in the nucleus to be effective. However, significant
that GR could be a component of a Parc complex.fractions of wild-type p53 protein are found in the cyto-
In addition to its likely participation in malignant trans-plasm of some tumors, such as neuroblastoma and in-
formation of certain cell types, Parc may play a roleflammatory breast carcinoma, suggesting that the se-
during normal development. Although cytoplasmic se-questration of p53 in the cytoplasm may represent a
questration of p53 was initially reported as an unusualnonmutational mechanism of p53 inactivation (Moll et
occurrence in inflammatory breast carcinoma, p53 canal., 1992). Gu and colleagues (Nikolaev et al., 2003 [this
be found in the cytoplasm of wild-type cells in the mam-issue of Cell]) now report the identification of a new
mary gland during lactation and in embryonic stem cellsfactor, Parc (p53-associated parkin-like cytoplasmic
(Moll et al., 1992; Aladjem et al., 1998). Thus, the anchor-protein), that binds to p53 in the cytoplasm and prevents
ing of p53 in the cytoplasm may be a conditional physio-its transport into the nucleus. The observations that
logic process in some cell types. In light of the findingsneuroblastoma cells appear to express particularly high
by Gu and colleagues, it is tempting to speculate thatlevels of Parc and that downregulation of Parc levels
Parc participates in this process, which becomes dereg-can induce apoptosis of a tumor cell line and sensitize
ulated during tumorigenesis.
neuroblastoma cells to chemotherapy provide immedi-
Neuroblastoma is the most common extracranial solid
ate physiologic importance to this discovery.
malignancy in children, and unfortunately, the prognosis
The exact mechanism by which Parc functions as a for this disease is frequently dismal. Most of these tu-
cytoplasmic anchor for p53 may be complex. The pro- mors express high levels of cytoplasmic wild-type p53,
tein is rather large (270 KDa), ubiquitously expressed, a feature that may contribute to an attenuated DNA
and maintained in a megacomplex (1 MDa) within the damage response and consequently the poor progno-
cytoplasm. Parc harbors several domains, including sis. Interestingly, Gu and coworkers link p53 cyto-
Ring-IBR-Ring and CCH signature motifs, which are plasmic sequestration in neuroblastomas to Parc based
found in proteins (e.g., Parkin and Cullins) that control on the following discoveries. (1) Parc is overexpressed
ubiquitin ligase activities. Collectively, these findings in neuroblastoma cell lines. (2) A large fraction of total
suggest that Parc regulates protein stability through ubi- cytoplasmic p53 is bound to Parc. (3) Suppression of
quitination. Although there is no direct evidence to indi- Parc expression by RNAi causes high levels of transcrip-
cate that Parc modifies p53 or regulates its stability, tionally active p53 to accumulate in the nucleus. (4) Re-
Parc does exhibit an intrinsic ubiquitin ligase activity. duction of Parc levels result in the marked sensitization
In addition to cytoplasmic sequestration of p53 medi- of neuroblastoma cells to DNA-damaging agents. There-
ated by Parc, cytoplasmic accumulation of p53 in neuro- fore, the mechanism by which Parc prevents p53 from
blastoma cells can occur by “hyperactive” nuclear ex- translocating to the nucleus becomes a potentially inter-
port via Mdm2, a Ring-finger protein that negatively esting target for tumor-specific therapy (see Figure). A
regulates p53 by promoting nuclear export and ubiqui- therapeutic molecule that could disrupt Parc’s hold on
tin-dependent proteolysis (Stommel et al., 1999). In- p53 in the cytoplasm of neuroblastoma cells could se-
deed, inhibition of MDM2 expression or function in neu- lectively kill neuroblastoma cells or arrest their growth,
roblastoma cells triggers the redistribution of functional with or without the addition of a DNA-damaging agent.
p53 into the nucleus (Lu et al., 2000). Therefore, the Normal cells without significant levels of p53 seques-
extent to which p53 accumulates within the cytoplasm tered in the cytoplasm would not be expected to be
and presumably loses tumor suppressor function de- significantly affected by such an agent. Here, as pre-
pends on the rates of cytoplasmic retention and nuclear viously reported by Goldman et al. (1996), Gu and
colleagues found that exposure of the cells to DNA-export, mediated by Parc and Mdm2, respectively.
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Cytoplasmic Sequestration of p53 by Parc
Neuroblastomas can overexpress Parc,
which sequesters p53 within the cytoplasm,
possibly by tethering p53 to the cytoskeleton.
In addition to facilitating p53 degradation,
Mdm2 also fosters p53 cytoplasmic localiza-
tion by enhancing its export from the nucleus.
Interference with Parc expression through
RNAi results in nuclear translocation of p53
and apoptosis.
damaging agents still caused a rapid stabilization and Toxin-Antitoxin Pairs in Bacteria:
translocation of p53 into the nucleus, despite sequestra- Killers or Stress Regulators?tion of p53 by Parc in the cytoplasm of cells before
exposure. Parc’s lack of effect on the translocation of
p53 in cells after DNA damage will need to be reconciled
with its apparently profound effect on apoptosis after
Plasmid toxin-antitoxin systems, which kill daughterDNA damage. Future studies addressing this and other
cells that fail to inherit the plasmid genome, have chro-questions will likely provide interesting mechanistic in-
mosomal homologs in eubacteria and archaea. In thissights about the interactions between stress responses
issue of Cell, Pederson et al. show that the E. coli RelEand p53-Parc interactions.
toxin cleaves mRNA in the ribosomal A site, potentially
allowing it to function as a stress regulator during
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